SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter who wrote (125)12/1/1997 11:49:00 PM
From: Richard Cohen  Read Replies (2) of 942
 
FWIW, I"m a family doc who has dozens of patients on Rezulin. Most are relieved to be on the drug because the only alternative is insulin injections. Most are on other medications which they are on require lab drawn every 3-4 months anyway(lipid lowering meds, diuretics, etc.) Unless they(WLA) downright pull they drug off the market, I don't plan to change my Rx habits at all. 99% of these patients have medical plans that cover the cost of the drug and the required testing. If you were a patient and your choice was this drug or daily insulin injections, what would you do? I think the prudent thing to do is wait and see if these patients with reactions had underlying hepatic dysfunction or this is a drug interaction or idiosyncratic reaction. I would expect significant liver pathology to surface earlier in the drug trials. Good Luck All, Rich Cohen
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News